As Venture Advisor, Elaine supports the overall business commercialization efforts including assisting with market assessments, development of business strategies, evaluation of Business Plans, competitor analysis, preparation of investor presentations and facilitating access to the Angel and / or Venture Capital Markets.
Elaine also manages the Oklahoma Proof-of-Concept Center, which is a collaboration with The Oklahoma Center for the Advancement of Science and Technology , the University of Oklahoma’s Office of Technology Development, Oklahoma State University’s Office of Intellectual Property Management and Licensing, and Cowboy Technologies, LLC.
Prior to joining i2E, Elaine Hamm served as the director for the University of Oklahoma’s Office of Technology Development, overseeing OU’s intellectual property management, economic development, and technology-based entrepreneurial activities for the Norman and Tulsa campuses. While at OU, she managed a diverse technology portfolio including but not limited to: oil and gas, weather, biotechnology, medical, alternative energy, and telecommunications engineering and was responsible for the technical evaluation as well as marketing, licensing, and commercialization of patents, copyrights, and other intellectual property developed at OU.
Dr. Hamm started her career as the Senior Protein Chemist for a pharmaceutical company where she was involved in drug development efforts against Alzheimer’s disease. Her academic research focused primarily on infectious disease and hospital-acquired illnesses. In addition to her foundation in research and drug development, Dr. Hamm spent many years developing a therapeutic and companion diagnostic/prognostic kit for Clostridium difficile–associated disease. Dr. Hamm received her Ph.D. in Microbiology from the University of Oklahoma and was post-doctoral fellow at the University of Oklahoma Health Sciences Center.